Chemokines in cancer

Dendritic cells and the control of immunity

Banchereau, J., & Steinman, R. M. (1998) · Nature · doi:10.1038/32588 · Cited by 14,496

Two subsets of memory T lymphocytes with distinct homing potentials and effector functions

Sallusto, F., Lenig, D., Förster, R., Lipp, M., & Lanzavecchia, A. (1999) · Nature · doi:10.1038/44385 · Cited by 5,846

Involvement of chemokine receptors in breast cancer metastasis

Müller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M. E., McClanahan, T., Murphy, E., Yuan, W., Wagner, S. N., et al. (2001) · Nature · doi:10.1038/35065016 · Cited by 5,340

The distribution of secondary growths in cancer of the breast.

Paget, S. (1889) · The Lancet · doi:10.1016/s0140-6736(00)49915-0 · Cited by 5,277

Chemokines

Zlotnik, A., & Yoshie, O. (2000) · Immunity · doi:10.1016/s1074-7613(00)80165-x · Cited by 3,923

A CD4+T-cell subset inhibits antigen-specific T-cell responses and prevents colitis

Groux, H., O’Garra, A., Bigler, M., Rouleau, M., Antonenko, S. V., de Vries, J. E., & Roncarolo, M. G. (1997) · Nature · doi:10.1038/39614 · Cited by 3,588

Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF.

Fadok, V. A., Bratton, D. L., Konowal, A., Freed, P. W., Westcott, J. Y., & Henson, P. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1112 · Cited by 3,166

The Biology of Chemokines and their Receptors

Rossi, D., & Zlotnik, A. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.217 · Cited by 2,410

Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs

Albert, M. L., Sauter, B., & Bhardwaj, N. (1998) · Nature · doi:10.1038/32183 · Cited by 2,350

CCR7 Coordinates the Primary Immune Response by Establishing Functional Microenvironments in Secondary Lymphoid Organs

Förster, R., Schubel, A., Breitfeld, D., Kremmer, E., Renner‐Müller, I., Wolf, E., & Lipp, M. (1999) · Cell · doi:10.1016/s0092-8674(00)80059-8 · Cited by 2,348

CCX-CKR Expression in Colorectal Cancer and Patient Survival

Zhu, Y., Tang, W., Liu, Y., Wang, G., Liang, Z., & Cui, L. (2014) · The International Journal of Biological Markers · doi:10.5301/jbm.5000057 · Cited by 25

Colon carcinoma cells induce CXCL11-dependent migration of CXCR3-expressing cytotoxic T lymphocytes in organotypic culture

Berencsi, K., Meropol, N. J., Hoffman, J. P., Sigurdson, E. R., Giles, L. R., Rani, P., Somasundaram, R., Zhang, T., Kalabis, J., Caputo, L., et al. (2006) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-006-0190-2 · Cited by 25

KIT Exon 11 Codons 557–558 Deletion Mutation Promotes Liver Metastasis Through the CXCL12/CXCR4 Axis in Gastrointestinal Stromal Tumors

Wang, H., Li, T., Chao, Y., Hou, Y., Hsueh, Y., Hsu, K.-H., & Shan, Y. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2748 · Cited by 25

Al[18F]NOTA-T140 Peptide for Noninvasive Visualization of CXCR4 Expression

Yan, X., Niu, G., Wang, Z., Yang, X., Kiesewetter, D. O., Jacobson, O., Shen, B., & Chen, X. S. (2015) · Molecular Imaging and Biology · doi:10.1007/s11307-015-0872-2 · Cited by 25

The role of CXCL12 axis in pancreatic cancer: New biomarkers and potential targets

Roberto, M., Arrivi, G., Civita, M. A. D., Barchiesi, G., Pilozzi, E., Marchetti, P., Santini, D., Mazzuca, F., & Tomao, F. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1154581 · Cited by 26

An agarose spot chemotaxis assay for chemokine receptor antagonists

Vinader, V. M., Al-saraireh, Y. M., Wiggins, H. L., Rappoport, J. Z., Shnyder, S. D., Patterson, L. H., & Afarinkia, K. (2011) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2011.01.004 · Cited by 24

Chemokine polymorphisms and lymphoma: a pooled analysis

Bracci, P. M., Skibola, C. F., Conde, L., Halperin, E., Lightfoot, T. J., Smith, A. G., Paynter, R. A., Skibola, D. R., Agana, L., Roman, E., et al. (2009) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428190903518337 · Cited by 24

Current View of the Role of Transforming Growth Factor β 1 in Skin Carcinogenesis

Li, A. G., Lu, S., Han, G., Kulesz-Martin, M. F., & Wang, X. (2005) · Journal of Investigative Dermatology Symposium Proceedings · doi:10.1111/j.1087-0024.2005.200403.x · Cited by 24

Anti-angiogenic peptides application in cancer therapy; a review

Shoari, A., Khodabakhsh, F., Cohan, R. A., Salimian, M., & Karami, E. (2021) · Research in Pharmaceutical Sciences · doi:10.4103/1735-5362.327503 · Cited by 23

What's new in the field of cancer vaccines?

Renno, T., Renard, N., Saeland, S., & Vicari, A. P. (2003) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-003-2185-x · Cited by 22

Serum concentration modifies amplitude and kinetics of voltage-gated Na+ current in the Mat-LyLu cell line of rat prostate cancer

Ding, Y., & Djamgoz, M. B. A. (2004) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2003.10.010 · Cited by 23

ROR-α-1 inhibits the proliferation, invasion, and migration of hepatocellular carcinoma MHCC97H via downregulation of chemokine CXCL5

Liu, G., Yang, Z., Zhou, P., Zhou, C., Guan, R., Sun, B., Fan, J., Zhou, J., Yi, Y., & Qiu, S. (2020) · Cytokine · doi:10.1016/j.cyto.2020.155004 · Cited by 22

Nordy, a synthetic lipoxygenase inhibitor, inhibits the expression of formylpeptide receptor and induces differentiation of malignant glioma cells

Chen, J., Bian, X., Yao, X., Gong, W., Hu, J., Chen, K., Iribarren, P., Zhao, W., & Zhou, X. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.02.113 · Cited by 22

Chemokine RANTES Promoter Dimorphisms and Hepatocellular Carcinoma Occurrence in Patients with Alcoholic or Hepatitis C Virus–Related Cirrhosis

Charni, F., Sutton, A., Rufat, P., Laguillier, C., Mansouri, A., Moreau, R., Ganne‐Carrié, N., Trinchet, J., Beaugrand, M., Charnaux, N., et al. (2011) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-11-0341 · Cited by 22

Chemokines—What Is Their Role in Colorectal Cancer?

Pączek, S., Łukaszewicz‐Zając, M., & Mroczko, B. (2020) · Cancer Control · doi:10.1177/1073274820903384 · Cited by 22

Role of Homeostatic Chemokine and Sphingosine‐1‐Phosphate Receptors in the Organization of Lymphoid Tissue

Müller, G., Reiterer, P., Höpken, U. E., Golfier, S., & Lipp, M. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb06038.x · Cited by 22

High expression level of CXCL1/GROα is linked to advanced stage and worse survival in uterine cervical cancer and facilitates tumor cell malignant processes

Man, X., Yang, X., Wei, Z., Tan, Y., Li, W., Jin, H., & Wang, B. (2022) · BMC Cancer · doi:10.1186/s12885-022-09749-0 · Cited by 21

Current treatments for advanced melanoma and introduction of a promising novel gene therapy for melanoma (Review)

Heo, J., Kim, N., Cho, J., & Choi, K.-C. (2016) · Oncology Reports · doi:10.3892/or.2016.5032 · Cited by 21

Identification and immunoprofiling of key prognostic genes in the tumor microenvironment of hepatocellular carcinoma

Wang, T.-B., Chen, B., Meng, T., Liu, Z., & Wu, W. (2021) · Bioengineered · doi:10.1080/21655979.2021.1918538 · Cited by 20

Y-box binding protein 1 expression in gastric cancer subtypes and association with cancer neovasculature

Wu, Y., Wang, K., Li, Z., Liu, Y., Izumi, H., Yamada, S., Uramoto, H., Nakayama, Y., Ito, K., & Kohno, K. (2014) · Clinical & Translational Oncology · doi:10.1007/s12094-014-1208-4 · Cited by 19

Differential expression profile of CXCR3 splicing variants is associated with thyroid neoplasia. Potential role in papillary thyroid carcinoma oncogenesis?

Urra, S., Fischer, M. C., Martínez, J. R. W., Véliz, L. P., Orellana, P., Solar, A. A., Böhmwald, K., Kalergis, A. M., Riedel, C. A., Corvalán, A. H., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.23502 · Cited by 19

CFTR Regulates the Proliferation, Migration and Invasion of Cervical Cancer Cells by Inhibiting the NF-κB Signalling Pathway

Wu, Z., Li, J., Zhang, Y., Hu, L., & Peng, X. (2020) · Cancer Management and Research · doi:10.2147/cmar.s252296 · Cited by 19

INTERFERON-γ UP-REGULATES TOLL-LIKE RECEPTOR 4 AND COOPERATES WITH LIPOPOLYSACCHARIDE TO PRODUCE MACROPHAGE-DERIVED CHEMOKINE AND INTERFERON-γ INDUCIBLE PROTEIN-10 IN HUMAN BLADDER CANCER CELL LINE RT4

Yamada, H., O’Donnell, M. A., Matsumoto, T., & Luo, Y. (2005) · The Journal of Urology · doi:10.1097/01.ju.0000168619.25341.96 · Cited by 19

Expression of chemokine receptor CXCR6 in human colorectal adenocarcinomas.

Wågsäter, D., & Dimberg, J. (2004) · PubMed · Cited by 19

The Ion Channel Gene KCNAB2 Is Associated with Poor Prognosis and Loss of Immune Infiltration in Lung Adenocarcinoma

Lyu, Y., Wang, Q., Liang, J., Zhang, L., & Zhang, H. (2022) · Cells · doi:10.3390/cells11213438 · Cited by 18

The Influence of Chemokine Receptor CCR2 Genotypes in the Route to Cervical Carcinogenesis

Coelho, A., Matos, A., Catarino, R., Pinto, D., de Sousa, H. M. L., Pereira, D., & Medeiros, R. (2007) · Gynecologic and Obstetric Investigation · doi:10.1159/000106492 · Cited by 18

Expression and function of Toll-like receptors in peripheral blood mononuclear cells from patients with ovarian cancer

Zhang, X., Xu, J., Xing, K., Zhang, S., Huang, P., Xu, T., Huang, L., Lou, J., Shi, X., Sun, R., et al. (2014) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-014-1632-x · Cited by 17

Relationships of Single Nucleotide Polymorphisms of Monocyte Chemoattractant Protein 1 and Chemokine Receptor 2 With Susceptibility and Clinicopathologic Characteristics of Neoplasia of Uterine Cervix in Taiwan Women

Wu, H., Lee, T., Tee, Y.-T., Chen, S., Yang, S., Lee, S.-K., Ko, J., & Wang, P.-H. (2013) · Reproductive Sciences · doi:10.1177/1933719113477481 · Cited by 17

Clinical significance of vascular endothelial growth factors C and D and chemokine receptor CCR7 in gastric cancer.

Deguchi, K., Ichikawa, D., Soga, K., Watanabe, K., Kosuga, T., Takeshita, H., Konishi, H., Morimura, R., Tsujiura, M., Komatsu, S., et al. (2010) · PubMed · Cited by 17

Tumor microenvironment in salivary gland carcinomas: An orchestrated state of chaos

Egal, É. S. A., Scarini, J. F., de Lima‐Souza, R. A., Lavareze, L., Fernandes, P. M., Emerick, C., Gonçalves, M. T., Helms, M. N., ALTEMANI, A. M. D. A. M., & Mariano, F. V. (2022) · Oral Oncology · doi:10.1016/j.oraloncology.2022.105777 · Cited by 17

Lack of Association of a Common Polymorphism in the 3'-UTR of Interleukin 8 with Non Small Cell Lung Cancer in Kashmir

Bhat, I. A., Pandith, A. A., Bhat, B. A., Naykoo, N. A., Qasim, I., Rasool, R., Aziz, S. A., & Shah, Z. A. (2013) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2013.14.7.4403 · Cited by 16

Review Biology of renal tumour cancer stem cells applied in medicine

Matak, D., Szymański, Ł., Szczylik, C. A., Śledziewski, R., Lian, F., Bartnik, E., Sobocińska, A. A., & Czarnecka, A. M. (2015) · Współczesna Onkologia · doi:10.5114/wo.2014.47128 · Cited by 16

High CLEC-2 expression associates with unfavorable postoperative prognosis of patients with clear cell renal cell carcinoma

Xiong, Y., Liu, L., Xia, Y., Wang, J., Xi, W., Bai, Q., Qu, Y., Long, Q., Xu, J., & Guo, J. (2016) · Oncotarget · doi:10.18632/oncotarget.11606 · Cited by 16

Structural Insights into the Interaction between a Potent Anti-inflammatory Protein, Viral CC Chemokine Inhibitor (vCCI), and the Human CC Chemokine, Eotaxin-1

Kuo, N.-W., Gao, Y., Schill, M. S., Isern, N., Dupureur, C. M., & LiWang, P. J. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.538991 · Cited by 16

Proteases and Protease Inhibitors: Implications in Antitumorigenesis and Drug Development

Pandey, R., Patil, N., & Rao, M. (2007) · International Journal of Human Genetics · doi:10.1080/09723757.2007.11885986 · Cited by 16

Molecular Mechanism Regarding Allosteric Modulation of Ligand Binding and the Impact of Mutations on Dimerization for CCR5 Homodimer

Zhang, F., Yuan, Y., Xiang, M., Guo, Y., Li, M., Liu, Y., & Pu, X. (2019) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.8b00850 · Cited by 16

RANKL/RANK interaction promotes the growth of cervical cancer cells by strengthening the dialogue between cervical cancer cells and regulation of IL-8 secretion

Shang, W.-Q., Li, H., LIU, L.-B., Chang, K., YU, J.-J., Xie, F., Li, M., & Yu, J. (2015) · Oncology Reports · doi:10.3892/or.2015.4303 · Cited by 15

Kinetics of Host Cell Recruitment During Dissemination of Diffuse Malignant Peritoneal Mesothelioma

Miselis, N. R., Lau, B. W., Wu, Z. J., & Kane, A. B. (2010) · Cancer Microenvironment · doi:10.1007/s12307-010-0048-1 · Cited by 15

Harvesting Low Molecular Weight Biomarkers Using Gold Nanoparticles

Khoury, L. R., Goldbart, R., Traitel, T., Enden, G., & Kost, J. (2015) · ACS Nano · doi:10.1021/nn507467y · Cited by 15

The Ubiquitin E3 Ligase Cbl-b in T Cells Tolerance and Tumor Immunity

Loeser, S., & Penninger, J. M. (2007) · Cell Cycle · doi:10.4161/cc.6.20.4797 · Cited by 15

Chemokine CCL27 is a novel plasma biomarker for identification the nasopharyngeal carcinoma patients from the Epstein-Barr virus capsid antigen-specific IgA seropositive population

Mao, M., Xue, N., Wang, X., Chi, P., Liu, Y., Huang, Q., Dai, S., & Liu, W. (2018) · BMC Cancer · doi:10.1186/s12885-017-3718-2 · Cited by 14

Chronic cadmium exposure decreases the dependency of MCF7 breast cancer cells on ERα

Bloomfield, M., & Louie, M. C. (2019) · Scientific Reports · doi:10.1038/s41598-019-46912-3 · Cited by 14

Effects of Ulinastatin and Cyclophosphamide on the Growth of Xenograft Breast Cancer and Expression of CXC Chemokine Receptor 4 and Matrix Metalloproteinase-9 in Cancers

Sun, Z., Yzu, T., Chen, J., Sun, X., Gao, F., Zhao, X., & Luo, J. (2010) · Journal of International Medical Research · doi:10.1177/147323001003800323 · Cited by 14

The Role of Chemokines and their Receptors in Tumor Progression and Invasion: Potential New Targets of Biological Therapy

Allavena, P., Marchesi, F., & Mantovani, A. (2005) · Current Cancer Therapy Reviews · doi:10.2174/1573394052952483 · Cited by 14

Peritoneal Immune System in Patients with Advance Epithelial Ovarian Cancer

Wertel, I., Nowicka, A., Rogala, E., & Kotarski, J. (2011) · International Reviews of Immunology · doi:10.3109/08830185.2011.569902 · Cited by 13

Gene Therapy to Improve Migration of T Cells to the Tumor Site

Stasi, A. D., Angelis, B. D., & Savoldo, B. (2010) · Methods in molecular biology · doi:10.1007/978-1-60761-786-0_7 · Cited by 13

N-terminal polypeptide derived from vMIP-II exerts its antitumor activity by inhibiting the CXCR4 pathway in human glioma

Yang, Q., Wu, H., Wang, H., Li, Y., Zhang, L., Zhu, L., Wang, W., Zhou, J., Fu, Y., Chen, S., et al. (2017) · International Journal of Oncology · doi:10.3892/ijo.2017.3906 · Cited by 13

Glycerophosphoinositol-4-phosphate enhances SDF-1α-stimulated T-cell chemotaxis through PTK-dependent activation of Vav

Patrussi, L., Mariggiò, S., Paccani, S. R., Capitani, N., Zizza, P., Corda, D., & Baldari, C. T. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2007.07.014 · Cited by 13

Expression of stromal cell-derived factor 1 and CXCR7 ligand receptor system in pancreatic adenocarcinoma

Liu, Z., Teng, X., Meng, X., & Wang, B. (2014) · World Journal of Surgical Oncology · doi:10.1186/1477-7819-12-348 · Cited by 12

[Detection of Chemerin and It's Clinical Significance in Peripheral Blood of Patients with Lung Cancer.].

Qu, X., Han, L., Wang, S.-C., Zhang, Q., Yang, C., Xu, S., & Zhang, L. (2009) · PubMed · doi:10.3779/j.issn.1009-3419.2009.11.09 · Cited by 12

Exploring CCL11 in breast cancer: unraveling its anticancer potential and immune modulatory effects involving the Akt-S6 signaling

Chen, X., Meng, C., Wang, X., Wu, Z., Sun, X., Sun, C., Zheng, L., Li, W., Jia, W., & Tang, T. (2024) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-023-05600-6 · Cited by 11

Topotecan inhibits cancer cell migration by down-regulation of chemokine CC motif receptor 7 and matrix metalloproteinases

Lin, S., Sun, L., Zhang, Y.-K., Zhao, R., Liang, W., Yuan, S., & Zhang, L. (2009) · Acta Pharmacologica Sinica · doi:10.1038/aps.2009.32 · Cited by 11

A NOVEL EXPRESSION OF MACROPHAGE DERIVED CHEMOKINE IN HUMAN BLADDER CANCER

Yamada, H., Luo, Y., Matsumoto, T., & O’Donnell, M. A. (2005) · The Journal of Urology · doi:10.1097/01.ju.0000155188.04120.f8 · Cited by 11

Low CCL17 expression associates with unfavorable postoperative prognosis of patients with clear cell renal cell carcinoma

Xiong, Y., Liu, L., Xia, Y., Wang, J., Xi, W., Bai, Q., Qu, Y., Xu, J., & Guo, J. (2017) · BMC Cancer · doi:10.1186/s12885-017-3106-y · Cited by 11

The Serum Levels of the Soluble Factors sCD40L and CXCL1 Are Not Indicative of Endometriosis

Pateisky, P., Pils, D., Kuessel, L., Szabo, L., Walch, K., Obwegeser, R., Wenzl, R. J., & Yotova, I. (2016) · BioMed Research International · doi:10.1155/2016/2857161 · Cited by 10

Tryptase-Positive Mast Cells Correlate with Angiogenesis in Canine Mammary Carcinoma

Im, K.-S., Kim, J. H., Yhee, J. Y., Yu, C.-H., Kim, N.-H., Nho, W.-G., & Sur, J. (2010) · Journal of Comparative Pathology · doi:10.1016/j.jcpa.2010.08.006 · Cited by 10

Association of polymorphisms in the MCP-1 and CCR2 genes with the risk of cancer: A meta-analysis

Cho, Y. A., & Kim, J. (2013) · Cytokine · doi:10.1016/j.cyto.2013.06.319 · Cited by 9

Chemokines in Homeostasis and Cancers

Abroun, S. (2008) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 8

Breast Cancer Progression: A “Vicious Cycle” of Pro-Malignancy Activities is Mediated by Inflammatory Cells, Chemokines and Cytokines

Ben‐Baruch, A. (2005) · Springer eBooks · doi:10.1007/1-4020-3414-8_11 · Cited by 9

Repurposing metformin as a potential anticancer agent using in silico technique

Mahfauz, M., Yuruker, O., & Kalkan, R. (2024) · DARU Journal of Pharmaceutical Sciences · doi:10.1007/s40199-024-00523-0 · Cited by 8

Inflammatory and Innate Immune Cells in Cancer Microenvironment and Progression

Brennecke, P., Allavena, P., Laface, I., Mantovani, A., & Bottazzi, B. (2014) · Springer eBooks · doi:10.1007/978-3-662-44006-3_2 · Cited by 8

CXCR4 Expression in Bladder Transitional Cell Carcinoma and Its Relationship with Clinicopathological Features

Li, Y., Chen, M., Yuan, J., Zhou, X., He, W., Zu, X., & Lin, Q. (2013) · Urologia Internationalis · doi:10.1159/000351952 · Cited by 8

Role of CD4 T lymphocytes in antitumor immunity

Rajnavölgyi, É., & Lányi, Á. (2003) · Advances in cancer research · doi:10.1016/s0065-230x(03)87209-3 · Cited by 8

Combination vaccine of dendritic cells (DCs) and T cells effectively suppressed preestablished malignant melanoma in mice

Asada, H., Kishida, T., Hirai, H., Shin‐Ya, M., Imanishi, J., Takeuchi, M., & Mazda, O. (2005) · Cancer Letters · doi:10.1016/j.canlet.2005.08.030 · Cited by 8

Role of CD4+ T lymphocytes in antitumor immunity

Rajnavölgyi, É., & Lányi, Á. (2003) · Advances in cancer research · doi:10.1016/s0065-230x(03)87298-6 · Cited by 8

Comprehensive analysis and immune landscape of chemokines- and chemokine receptors-based signature in hepatocellular carcinoma

Zhang, Z., Mao, M., Wang, F., Zhang, Y., Shi, J., Chang, L., Wu, X., Zhang, Z., Xu, P., & Lu, S. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1164669 · Cited by 7

Chemokines and Their Receptors: Predictors of Therapeutic Potential in Tumor Microenvironment on Esophageal Cancer

Huang, C., Liu, Q., Zheng, S., Liu, T., Tan, Y., Peng, T., Chen, J., & Lu, X. (2024) · Digestive Diseases and Sciences · doi:10.1007/s10620-024-08392-y · Cited by 7

The effect of C-X-C motif chemokine ligand 13 in cutaneous squamous cell carcinoma treated with aminolevulinic acid-photodynamic therapy

Zhu, L., Zhang, G., Wang, P., Zhang, L., Ji, J., Liu, X., Zhou, Z., Zhao, J., & Wang, X. (2019) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2019.04.018 · Cited by 7

Infection & neoplastic growth 101: the required reading for microbial pathogens aspiring to cause cancer.

Bertout, J. A., & Thomas‐Tikhonenko, A. (2006) · PubMed · Cited by 7

Tumor interstitial fluid and postoperative recurrence of tumors: An experimental study for verifying hypothesis of “tumor-phlegm microenvironment”

Sun, D., Da-wei, J., He, J., Lu, Y. F., Wu, F. Y., Li, C., & Wei, P.-K. (2010) · Chinese Journal of Integrative Medicine · doi:10.1007/s11655-010-0537-6 · Cited by 7

Hypoxic Pulmonary Hypertension

Pugliese, S. C., Yeager, M. E., & Stenmark, K. R. (2014) · Springer eBooks · doi:10.1007/978-3-642-37393-0_206-1 · Cited by 6

The prognostic significance of circulating serum amyloid A and CXC chemokine ligand 4 in osteosarcoma

Flores, R. J., Kelly, A. J., Li, Y., Chen, X., McGee, C., Krailo, M., Barkauskas, D. A., Hicks, J. M., & Man, T. (2017) · Pediatric Blood & Cancer · doi:10.1002/pbc.26659 · Cited by 6

Role of Cytokines in Tumor Immunity and Immune Tolerance to Cancer

Murugaiyan, G. (2014) · Springer eBooks · doi:10.1007/978-3-662-44006-3_7 · Cited by 6

High plasma levels of oxidatively modified low-density lipoproteins are associated with the suppressed expression of immunomodulatory molecules in patients with hematological malignancies

Yang, H., Qiu, F.-Q., JIN, K., Jiang, N., & ZHANG, L. (2015) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2015.2392 · Cited by 6

Infection & Neoplastic Growth 101

Bertout, J. A., & Thomas‐Tikhonenko, A. (2006) · Cancer treatment and research · doi:10.1007/0-387-26283-0_8 · Cited by 6

Exploiting the Inherent Metastasis of Leukemia to Improve Chemotherapeutic Approaches

Trendowski, M. R. (2014) · Cell & Developmental Biology · doi:10.4172/2168-9296.1000137 · Cited by 6

Inflammation and Angiogenesis: Innate Immune Cells as Modulators of Tumor Vascularization

Mueller, M. M. (2007) · Springer eBooks · doi:10.1007/978-3-540-33177-3_20 · Cited by 5

Angiogenic switch in Barrett's adenocarcinoma: the role of vascular endothelial growth factor

Islam, A. (2006) · Frontiers in bioscience · doi:10.2741/1973 · Cited by 5

O papel das quimiocinas nas uveítes

Gonçalves, R. M., Teixeira, A. L., Campos, W. R., & Oréfice, F. (2007) · Arquivos Brasileiros de Oftalmologia · doi:10.1590/s0004-27492007000200033 · Cited by 5

The expression of CCL17 and potential prognostic value on tumor immunity in thyroid carcinoma based on bioinformatics analysis

Gu, X., Chen, B., Zhang, S., Zhai, X., Hu, Y., & Ye, H. (2024) · Scientific Reports · doi:10.1038/s41598-024-75750-1 · Cited by 4

Chemokine family significance and prognostic value in colorectal cancer

Ding, Y., Chen, Y., Xie, S., Qiu, Q., Guo, X., Feng, Y., Li, H., Zhu, F., & Liu, Y. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1404768 · Cited by 4

Multiplex Analysis of Cytokines Involved in Tumour Growth and Spontaneous Regression in a Rat Sarcoma Model

Strnádel, J., Kverka, M., Horák, V., Vannucci, L. E., Usvald, D., Hlučílová, J., Plánská, D., Váňa, P., Reisnerová, H., & Jílek, F. (2007) · Folia Biologica · doi:10.14712/fb2007053060216 · Cited by 4

Serum concentrations of CCL20/MIP-3alpha in women with endometriosis

Jabłoński, G., Sobkiewicz, B., Kaczmarek, M., Krygier, A., Bieńkiewicz, J., & Malinowski, A. (2019) · Menopause Review/Przegląd Menopauzalny · doi:10.5114/pm.2019.84151 · Cited by 4

Adoptive T-Cell Therapy: Optimizing Chemokine Receptor-Mediated Homing of T Cells in Cancer Immunotherapy

Siddiqui, I., Mantovani, A., & Allavena, P. (2014) · Springer eBooks · doi:10.1007/978-3-662-44946-2_14 · Cited by 4

CCR4 C1014T and CCL22 C16A genetic variations in the Iranian patients with colorectal adenocarcinoma.

Erfani, N., Ahrari, S., Ahrari, I., & Hosseini, S. V. (2014) · PubMed · Cited by 3

In vivo Survivors of Transformed Mouse Ovarian Surface Epithelial Cells Display Diverse Phenotypes for Gene Expression and Tumorigenicity

Li, X., Zhang, D., Wang, D., Knight, D. S., Yin, L., Bao, J. R., Liu, Y., Glass, J., Mathis, J. M., & Zhang, Q.-J. (2008) · Tumor Biology · doi:10.1159/000178981 · Cited by 3

Hypoxic Pulmonary Hypertension

Pugliese, S. C., Yeager, M. E., & Stenmark, K. R. (2015) · Springer eBooks · doi:10.1007/978-3-642-37078-6_206 · Cited by 3

CD192 gene variant and susceptibility to cervical cancer: a meta analysis.

Chen, Y., Liu, X., Chen, M., Shen, J. F., Lu, Y., Yu, L., & Liu, S. (2015) · Europe PMC (PubMed Central) · Cited by 2

Tumor-Associated Macrophages in Cancer Growth and Progression

Mantovani, A., Allavena, P., & Sica, A. (2007) · Elsevier eBooks · doi:10.1016/b978-012372551-6/50080-8 · Cited by 2

The Contribution of Immune Cells to Angiogenesis in Inflammation and Tumor Growth

Ribatti, D. (2017) · Springer eBooks · doi:10.1007/978-3-319-68448-2_7 · Cited by 3

THE ROLE OF GP130 CYTOKINES IL-6 AND OSM ON TUMOR DEVELOPMENT IN MOUSE MODELS FOR LUNG ADENOCARCINOMA

Lauber, S. (2012) · MacSphere (McMaster University) · doi:10.71548/15037 · Cited by 2

The Role of Hypoxia in Re-educating Macrophages in the Tumour Environment

Reuben, J. M., Claire, E., & Subhra, K. (2012) · InTech eBooks · doi:10.5772/48976 · Cited by 1

The Tumor Microenvironment as Target for New Cancer Therapies

Schwendener, R. A., & Mete, S. (2014) · Cited by 1

Tumor-associated Macrophages in Cancer Growth and Progression

Mantovani, A., Galdiero, M. R., Allavena, P., & Sica, A. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-394296-8.00027-0 · Cited by 1

The Effects of Radiation on Cancer Immunology

Lu, Y. (2020) · Novel Approaches in Cancer Study · doi:10.31031/nacs.2020.04.000595 · Cited by 1

Immune Surveillance and Cancer Pathogenesis

Mastrangelo, D. (2005) · Springer eBooks · doi:10.1007/0-387-27086-8_2 · Cited by 1

Chemokine and Receptor Expression in Tumor Progression

Allavena, P., Marchesi, F., & Mantovani, A. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-455-1_15 · Cited by 1

CXCR4 in Central and Peripheral Lymphoid Niches – Physiology, Pathology and Therapeutic Perspectives in Immune Deficiencies and Malignancies

Freitas, C., Bignon, A., Balabanian, K., & Dalloul, A. H. (2014) · InTech eBooks · doi:10.5772/58699 · Cited by 1

Role of Kynurenine Pathway in Cancer Biology

Mowat, C. G. (2015) · Springer eBooks · doi:10.1007/978-3-319-11870-3_21 · Cited by 1

Inhibition of tumor growth by adenovirus-mediated expression of antiangiogenic and immunomodulatory proteins

Vijayshankar, S. G. (2006) · Kölner Universitäts PublikationsServer (Universität zu Köln) · Cited by 1

The diverse role of chemokines in tumor progression: Prospects for intervention (Review)

Schneider, G., Salcedo, R., Welniak, L., Howard, O. M. Z., & Murphy, W. J. (2001) · International Journal of Molecular Medicine · doi:10.3892/ijmm.8.3.235 · Cited by 19

Chemokines and receptors in the development and progression of malignant tumors

Zhao, H., & Jiang, J. (2023) · Cytokine · doi:10.1016/j.cyto.2023.156335 · Cited by 14

Chemokines in tumor-associated angiogenesis

Gerber, P. A., Hippe, A., Buhren, B. A., Müller, A., & Homey, B. (2009) · Biological Chemistry · doi:10.1515/bc.2009.144 · Cited by 73

Chemokine signaling in cancer: Implications on the tumor microenvironment and therapeutic targeting.

Hembruff, S. L., & Cheng, N. (2009) · PubMed · Cited by 70

Chemokines and Metastasis

Nannuru, K. C., Singh, S., & Singh, R. K. (2010) · Springer eBooks · doi:10.1007/978-1-4419-6615-5_27 · Cited by 7